Table 1.
Patient Description | Numbers (%)/Range |
---|---|
Gender | Men 53 (65.4%) |
Women 28 (34.6%) | |
Age | 61 years; range: 35–82 years |
Primary Cancer Site | |
Colon | 52 (64.2%) |
Rectum | 29 (35.8%) |
Prior Chemotherapy | 81 (100%) |
Hepatic Metastases Description | |
Patients with single nodule | 52 (64.2%) |
Patients with multiple nodules | 29 (35.8%)/range: 2–13 metastases |
Nodule size (mm) | mean size 36.4 mm; range 7–58 mm |
Front of Tumor Growth | |
expansive | 30 (37.0%) |
infiltrative | 51 (63.0%) |
Tumor Budding | |
Absent | 12 (14.8%) |
Low grade | 14 (17.3%) |
High grade | 55 (67.9%) |
Mucinous Carcinoma | 25 (30.9%) |
Recurrence | 19 (23.5%) |
RAS Mutation | 42 (51.9%) |